Literature DB >> 24633857

A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study.

Margot M Koeneman1, Arnold-Jan Kruse, Simone J S Sep, Cynthia S Gubbels, Brigitte F M Slangen, Toon van Gorp, Alberto Lopes, Encarna Gomez-Garcia, Roy F P M Kruitwagen.   

Abstract

Pilot study to evaluate whether the use of a standardized questionnaire to document family history of cancer improves identification of women who warrant referral to cancer genetic services (CGS) for increased risk of hereditary cancer, compared to their identification in usual care. Prospective intervention study with historic control group. Gynecology outpatient clinic, Maastricht University Medical Centre, the Netherlands. The prospective intervention group consisted of new outpatients between June 1 and August 1, 2011. The historic control group consisted of new outpatients between May 1, 2009 and April 30, 2010. A standardized questionnaire based on established referral criteria for hereditary breast/ovarian cancer and Lynch syndrome was completed for the intervention group. The referral rate in routine consultation, based on non-standardized family history recording, was determined retrospectively for the control group. The difference in referral rate between intervention and control group, tested by Chi square test. In the control group, 8 of 3,036 women (0.26 %) were referred to CGS. In the intervention group, 209 (42 %) of 500 screening questionnaires were completed. Nineteen women (9, 1 %) met the referral guidelines, of which 5 were newly referred to CGS (2, 4 %). Referral rates differed significantly (p < 0.001) between the two groups. This pilot study shows that the routine use of a screening questionnaire may improve detection and referral rate to CGS of individuals at risk for hereditary cancer. Improving genetic literacy of physicians and use of web-site questionnaires deserve attention in future studies.

Entities:  

Mesh:

Year:  2014        PMID: 24633857     DOI: 10.1007/s10689-014-9711-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

1.  Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.

Authors:  Anne Lanceley; Zara Eagle; Gemma Ogden; Sue Gessler; Khalil Razvi; Jonathan A Ledermann; Lucy Side
Journal:  Int J Gynecol Cancer       Date:  2012-02       Impact factor: 3.437

2.  Clinically relevant changes in family history of cancer over time.

Authors:  Argyrios Ziogas; Nora K Horick; Anita Y Kinney; Jan T Lowery; Susan M Domchek; Claudine Isaacs; Constance A Griffin; Patricia G Moorman; Karen L Edwards; Deirdre A Hill; Jonathan S Berg; Gail E Tomlinson; Hoda Anton-Culver; Louise C Strong; Carol H Kasten; Dianne M Finkelstein; Sharon E Plon
Journal:  JAMA       Date:  2011-07-13       Impact factor: 56.272

Review 3.  A literature review of the psychological impact of genetic testing on breast cancer patients.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Margreet G E M Ausems
Journal:  Patient Educ Couns       Date:  2005-10-19

4.  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Authors:  Tuan A Dinh; Benjamin I Rosner; James C Atwood; C Richard Boland; Sapna Syngal; Hans F A Vasen; Stephen B Gruber; Randall W Burt
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-18

Review 5.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.

Authors:  Larissa A Meyer; Russell R Broaddus; Karen H Lu
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

6.  Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

Authors:  Shilpa Grover; Elena M Stoffel; Laoti Bussone; Elizabeth Tschoegl; Sapna Syngal
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

7.  Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.

Authors:  Ian Teng; Allan Spigelman
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 8.  How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX.

Authors:  Maged N Kamel Boulos; Steve Wheeler; Carlos Tavares; Ray Jones
Journal:  Biomed Eng Online       Date:  2011-04-05       Impact factor: 2.819

9.  Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey.

Authors:  Maren T Scheuner; Timothy S McNeel; Andrew N Freedman
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

10.  A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.

Authors:  E Wallace; A Hinds; H Campbell; J Mackay; R Cetnarskyj; M E M Porteous
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more
  6 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

Authors:  Kenta Masuda; Akira Hirasawa; Haruko Irie-Kunitomi; Tomoko Akahane; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Fumio Kataoka; Eiichiro Tominaga; Kouji Banno; Nobuyuki Susumu; Daisuke Aoki
Journal:  Jpn J Clin Oncol       Date:  2017-05-01       Impact factor: 3.019

3.  Patient's Experience in Pediatric Primary Immunodeficiency Disorders: Computerized Classification of Questionnaires.

Authors:  Urs Mücke; Christian Klemann; Ulrich Baumann; Almut Meyer-Bahlburg; Xiaowei Kortum; Frank Klawonn; Werner M Lechner; Lorenz Grigull
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

4.  Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

5.  Genetic variants within the cancer susceptibility region 8q24 and ovarian cancer risk in Han Chinese women.

Authors:  Jing Han; Jing Zhou; Hua Yuan; Longbiao Zhu; Hongxia Ma; Dong Hang; Dake Li
Journal:  Oncotarget       Date:  2017-05-30

6.  The design, implementation, and effectiveness of intervention strategies aimed at improving genetic referral practices: a systematic review of the literature.

Authors:  April Morrow; Priscilla Chan; Katherine M Tucker; Natalie Taylor
Journal:  Genet Med       Date:  2021-08-24       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.